LADENBURG THALMANN FINANCIAL SERVICES INC. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 69 filers reported holding CTI BIOPHARMA CORP in Q1 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2019$2,0001,110
+5450.0%
0.00%
Q3 2019$0200.0%0.00%
Q2 2019$0200.0%0.00%
Q1 2019$0200.0%0.00%
Q4 2018$0200.0%0.00%
Q3 2018$0200.0%0.00%
Q2 2018$0200.0%0.00%
Q1 2018$0200.0%0.00%
Q4 2017$0200.0%0.00%
Q3 2017$020
-83.3%
0.00%
Q2 2017$0
-100.0%
1200.0%0.00%
Q1 2017$1,0001200.00%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2019.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders